In summary, our evidence corroborates that Nrf1 functions as a dominant tumor repressor by intrinsic inhibition of the Wnt/β-catenin pathways and other signaling networks involved in human hepatoma development and progression. Here, NRF1 is linked to hepatocellular carcinoma.